Surgical Innovations Group plc
SUN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £5 | £6 | £15 | £22 |
| - Cash | £0 | £1 | £2 | £4 |
| + Debt | £1 | £2 | £2 | £3 |
| Enterprise Value | £6 | £6 | £15 | £21 |
| Revenue | £12 | £12 | £11 | £9 |
| % Growth | -0.6% | 5.9% | 24.3% | – |
| Gross Profit | £3 | £3 | £4 | £3 |
| % Margin | 28.8% | 28.7% | 34.6% | 34.3% |
| EBITDA | -£0 | £0 | £1 | £0 |
| % Margin | -0.8% | 1.3% | 5.5% | 2.7% |
| Net Income | -£2 | -£1 | £0 | -£0 |
| % Margin | -16.3% | -4.2% | 2.3% | -5% |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.001 |
| % Growth | -320% | -266.7% | 160% | – |
| Operating Cash Flow | -£0 | £0 | £0 | -£0 |
| Capital Expenditures | -£0 | -£1 | -£1 | -£1 |
| Free Cash Flow | -£0 | -£0 | -£1 | -£1 |